Is GE Healthcare Technologies, Inc. overvalued or undervalued?
As of October 17, 2025, GE Healthcare Technologies, Inc. is considered very attractive and undervalued, with a P/E ratio of 14, a PEG ratio of 0.39, and strong operational efficiency metrics, despite a recent stock decline of 18.47%.
As of 17 October 2025, the valuation grade for GE Healthcare Technologies, Inc. has moved from attractive to very attractive. The company is currently undervalued, supported by a P/E ratio of 14, a PEG ratio of 0.39, and an EV to EBITDA ratio of 11.16. In comparison to peers, GE Healthcare's P/E ratio is significantly lower than that of Edwards Lifesciences Corp., which stands at 31.17, indicating a more favorable valuation relative to its earnings.Despite recent stock performance showing a decline of 18.47% over the past year compared to a 14.08% return for the S&P 500, the company's strong ROE of 25.79% and ROCE of 18.89% suggest solid operational efficiency. Overall, these metrics reinforce the conclusion that GE Healthcare Technologies, Inc. is undervalued in the current market.
{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)
{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)
Related Stock Links
- {{stockdata.stock.stock_name.value}} Analysis
- {{stockdata.stock.stock_name.value}} Technicals
- {{stockdata.stock.stock_name.value}} Quality
- {{stockdata.stock.stock_name.value}} Valuation
- {{stockdata.stock.stock_name.value}} Financial Trend
- {{stockdata.stock.stock_name.value}} Return Analysis
- {{stockdata.stock.stock_name.value}} Price Analysis
- {{stockdata.stock.stock_name.value}} Quarterly Result Analysis
- {{stockdata.stock.stock_name.value}} Half-Yearly Result Analysis
- {{stockdata.stock.stock_name.value}} Nine Monthly Result Analysis
- {{stockdata.stock.stock_name.value}} Annual Results
- {{stockdata.stock.stock_name.value}} Balance Sheet
- {{stockdata.stock.stock_name.value}} Profit & Loss
- {{stockdata.stock.stock_name.value}} Cash Flow
- {{stockdata.stock.stock_name.value}} News
- {{stockdata.stock.stock_name.value}} Announcements
- {{stockdata.stock.stock_name.value}} Share Holding
- {{stockdata.stock.stock_name.value}} Peer Comparison
Our weekly and monthly stock recommendations are here
Loading...
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Target Price
{{sm.target_price }}
({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
₹{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Most Read
